相关实验视频
Updated: Jul 5, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
微RNA-181b-5p通过向编程细胞死亡促进甲状腺癌的生长 4
Xiang Geng1, Yuan Li1, YangYang Sun2
1Department of Thyroid and Breast Surgery, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, Changzhou City, 210029, Jiangsu Province, China.
微RNA-181b-5p通过向编程细胞死亡4 (PDCD4) 来促进甲状腺癌 (TC) 的进展. 抑制miR-181b-5p或恢复PDCD4抑制了瘤生长并增强了TC细胞的亡.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 甲状腺癌 (TC) 是一种普遍存在的内分泌恶性瘤.
- 了解驱动TC进展的分子机制对于开发向疗法至关重要.
研究的目的:
- 为了阐明微RNA (miR)-181b-5p在甲状腺癌中的作用.
- 通过向编程细胞死亡4 (PDCD4) 来研究miR-181b-5p的作用机制.
主要方法:
- 在TC组织中分析miR-181b-5p和PDCD4表达.
- 试验室试验评估miR-181b-5p和PDCD4对TC细胞增殖,迁移,入侵和亡的影响.
- 对miR-181b-5p/PDCD4相互作用的生物信息预测和实验验证.
主要成果:
- 在TC组织中,miR-181b-5p被显著上调,而PDCD4表达被下调.
- 下调miR-181b-5p或上调PDCD4可以抑制TC细胞的增殖,迁移和入侵,同时促进细胞亡.
- 证实PDCD4是miR-181b-5p的直接下游目标.
结论:
- miR-181b-5p通过向和降低PDCD4.4的调节来促进甲状腺癌的进展.
- 准miR-181b-5p/PDCD4轴为甲状腺癌提供了一个潜在的治疗策略.
更多相关视频
08:40Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
相关概念视频
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
The Intrinsic Apoptotic Pathway